Moo ho reka Velpatasvir (Epclusa)? Velpatasvir (Velpanat, Velasof): theko ka Russia

"Velpatasvir» (velpatasvir) - ke lithethefatsi e ncha pele ka Inc. Gileade E e sebediswa ea ho phekola lefu la sebete C. Tsela ho khetheha o atlehang e retelehela ho 2 le genotype 3 HCV. Le nako e telele kamoo moriana ho eena ka matla a ho le ea mong.

Motswako sofosbuvir (400 mg,) velpatasvirom (100 mg,) e reretsoe ho loantša efe kapa efe genotype hepatitis C kokoana-hloko 'me a le 100% lebaka leo, esita le haeba pele khanna phekolo e ne e se atleha. Ho ile ntshetswa pele United States, farmgigantom Gileade Inc, 'me e fumaneha ka foromo letlapa, ho bitsoa ka lebitso "Epklusa".

Sofosbuvir lokisetsa sena thibela RNA polymerase, eo ka eona le kokoana-hloko likopi tse RNA lona le velpatasvir ama NS5B polymerase, kahoo sitisoa ho qaloa ho liphatsa tsa lefutso le bongata ba kokwanahloko liseleng tloaelehileng.

Moo ho reka velpatasvir le sofosbuvir ka oa ho lokisetsa ho kopantswe?

Reka lipilisi "Epklusa" thata haholo, kaha ba na le tse fetang 60 000 li-euro bakeng sa likhoeli tse tharo 'nete hore ea phekolo, e leng, ha u ntse u tseba, kaha ba bangata ba bakuli feela ke ke ra khona. Ka lehlohonolo, ka 2017 | khampani Gileade fileng Indian khampani Hetero NATCO Pharma le lengolo la bao e seng bo khethehileng ho ikatisa le laesense generics: VELPANAT (NATCO) le VELASOF (HETERO). Reka velpatasvir + sofosbuvir hona joale ho ka khonehang India ka theko e nepahetseng.

Ho pholosa bakeng sa bakuli ba bangata ha e kopana - sofosbuvir + velpatasvir - ka rekoa online, kholo Indian distribyutorskoy WWW.HCV24.COM marangrang.

Ho odara, online Karela Epclusa Indian khampani, o hloka ho ba le litokomane tsa ho paka hore ho phekola lefu la sebete, c u hlile u hloka.

E le hore bakuli ba na le lipelaelo, a re ke re ka bolela hore karela - e ke manaka feletseng le diselefounu tsa ea lithethefatsi, e leng e hlahisoang ke theknoloji se tsoetseng pele, 'me ka hona ha e kenyeletsa theko ea ho qeta ka ho etsa lipatlisiso' me 'maraka ho phahamiswa. Ho ena, ho ena le boleng ba futsanehileng, joalokaha ba bang ba nahana hore, generics ke haholo ka theko e tlaase ho feta cha ho bolela.

Contraindications

Joalokaha u ka bona, ho bolela-ke ba bohlokoa haholo ho loantša bokuli bo tebileng. Empa pele u reka "Velpatasvir" kapa motswako lona le sofosbuvir, o lokela ho tseba hore basali sebelisa lithethefatsi nakong ea bokhachane le kanyeso, hammoho le banna ba, tabeng ea bokhachane molekane, litsebi li u se ke ua ho kgothaletsa.

U se ke ua laela sesebelisoa sena le bakuli tlaase ho lilemo tse lilemo tse 18, hammoho le le ho se mamellane ka bomong ba dikarolo lithethefatsi teng.

Ka hloko sebelisoa ka ho phekola bakuli ba baholo ho lilemo tse 65 'me a utloa bohloko ho tswa ho insufficiency matla renal.

Dosing

Lithethefatsi "Epklusa", hammoho le lona karela (sofosbuvir velpatasvir +), theko le mekhoa ea kopo tse tšohliloeng sehloohong sena, nka hang ka letsatsi Letlapa ngoe. Mokhoa oa ho kalafo hangata nka bakeng sa dikgwedi tse tharo.

Ka ho ba teng ha decompensated ho thatafala ha sebete (sehlopha sa B le C) mokuli buelloa ho eketsa 'nete hore ho ile ha feta libeke tse 24. Le tabeng ena, kalafo o etsoang tsoa ka hammoho le oa e le ba lokisetsa ho ea "ribavirin".

litla-morao

Pele U Reka "Velpatasvir" kapa motswako, 'me o lokela ho e tseba litla-morao tse ka etsahala nakong sebelisoa. Kahoo, bakuli ba ka 'na ba:

• ho tsekela;
• mafu a ea tlhokomelo le memoring ya;
• fainting;
• bokhutšoanyane phefumoloho;
• letšollo;
• khaello ea mali;
• pheriferale edema;
• hypothyroidism;
• lekhopho;
• kulisa;
• photosensitivity.

Maemo a ho lithethefatsi overdose "Velpatasvir", o ka reka e ka site ya sisintsweng, ha ho hlokometsoe.